P63165 (SUMO1_HUMAN) Homo sapiens (Human)
Small ubiquitin-related modifier 1 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
61 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Docked structure between SUMO1 and ZZ-domain from CBP |
Heteromer Q92793; | 100 | 2×ZN; | |||
| Phosphorylation of SUMO-interacting motif by CK2 enhances Daxx SUMO binding activity |
Heteromer Q9UER7; | 100 | ||||
| Ternary complex of SUMO1 with a phosphomimetic SIM of PML and zinc |
Heteromer P29590; | 98.82 | 4×ZN; | |||
| SUMO E1 ACTIVATING ENZYME SAE1-SAE2-SUMO1-MG-ATP COMPLEX |
Heteromer Q9UBE0; Q9UBT2; | 100 | 1×MG; 1×ZN; 1×ATP; | |||
| SENP1 (mutant) full length SUMO1 |
Heteromer Q9P0U3; | 100 | ||||
| Crystal structure of K45-acetylated SUMO1 in complex with phosphorylated PML-SIM |
Heteromer P29590; | 98.73 | ||||
| Crystal Structure of SUMO1-conjugated thymine DNA glycosylase |
Heteromer Q13569; | 100 | 3×CL; 5×MG; 1×NA; | |||
| Human SUMO E1 complex with a SUMO1-AMP mimic |
Heteromer Q9UBE0; Q9UBT2; | 98.73 | 1×ZN; 1×JZU; | |||
| Crystal Structure of the Monobody ySMB-9 bound to human SUMO1 |
Heteromer | 98.72 | ||||
| Structure of SUMO modified Ubc9 |
Heteromer P63280; | 100 | 4×FMT; 1×NA; | |||
| Complex between human RanGAP1-SUMO1, UBC9 and the IR1 domain from RanBP2 containing IR2 Motif II |
Heteromer P46060; P49792; P63279; | 100 | ||||
| Structure of human Senp2 in complex with SUMO-1 |
Heteromer Q9HC62; | 100 | 5×SO4; | |||
| Crystal structure of human SENP1 mutant (C603S) in complex with SUMO-1 |
Heteromer Q9P0U3; | 100 | ||||
| Crystal structure of the human SENP2 C548S in complex with the human SUMO1 K48M F66W |
Heteromer Q9HC62; | 97.44 | ||||
| Crystal structure of a complex between UBC9, SUMO-1, RANGAP1 and NUP358/RANBP2 |
Heteromer P46060; P49792; P63279; | 100 | ||||
| Molecular Determinants of Paralogue-Specific SUMO-SIM Recognition |
Heteromer P49792; | 100 | ||||
| Human RANBP2/RAN(GTP)/RANGAP1-SUMO1/UBC9/CRM1/RAN(GTP) - composite map and model |
Heteromer O14980; P46060; P49792; P62826; P63279; | 98.72 | 2×GTP; 2×MG; | |||
| Non-covalent complex between Ubc9 and SUMO1 |
Heteromer P63280; | 100 | 1×NA; | |||
| Crystal structure of K46-acetylated SUMO1 in complex with phosphorylated PML-SIM |
Heteromer P29590; | 98.7 | ||||
| Crystal Structure of SUMO1 in complex with PML |
Heteromer P29590; | 98.7 | ||||
| Crystal structure of SUMO1 in complex with phosphorylated PML |
Heteromer P29590; | 98.7 | ||||
| Structure of SUMO1-ML00752641 adduct bound to SAE |
Heteromer Q9UBE0; Q9UBT2; | 100.0 | 1×SO4; 1×ZN; 1×VBA; | |||
| Crystal structure of SUMO modified ubiquitin conjugating enzyme E2- 25K |
Heteromer P61085; | 100 | ||||
| Human SUMO E1~SUMO1-AMP tetrahedral intermediate mimic |
Heteromer Q9UBE0; Q9UBT2; | 98.7 | 3×EDO; 1×ZN; 1×VMX; | |||
| Mimetic of UBC9-SUMO1 |
Heteromer P63279; | 100 | 1×SO4; | |||
| Solution Structure of SUMO-1 in Complex with a SUMO-binding Motif (SBM) |
Heteromer O75928; | 100 | ||||
| SUMO1 bound to SLS4-SIM peptide from ICP0 |
Heteromer P08393; | 100 | ||||
| Complex of SUMO1 and phosphorylated hcmv protein IE2 |
Heteromer P19893; | 100 | ||||
| SUMO1 bound to phosphorylated SLS4-SIM peptide from ICP0 |
Heteromer P08393; | 100 | ||||
| Structure of SUMO1-ML786519 adduct bound to SAE |
Heteromer Q9UBE0; Q9UBT2; | 100.0 | 1×SO4; 1×ZN; 1×VAY; | |||
| Structure of SUMO1-ML00789344 adduct bound to SAE |
Heteromer Q9UBE0; Q9UBT2; | 100.0 | 1×SO4; 1×ZN; 1×VB7; | |||
| SENP1 (mutant) SUMO1 RanGAP |
Heteromer P46060; Q9P0U3; | 100 | ||||
| Crystal structure of K46-acetylated SUMO1 in complex with PML-SIM |
Heteromer P29590; | 98.67 | ||||
| Crystal structure of K39-acetylated SUMO1 in complex with PML-SIM |
Heteromer P29590; | 98.67 | ||||
| Crystal structure of K45-acetylated SUMO1 in complex with PML-SIM |
Heteromer P29590; | 98.67 | ||||
| Crystal structure of K37-acetylated SUMO1 in complex with phosphorylated PML-SIM |
Heteromer P29590; | 98.67 | ||||
| Crystal structure of K37-acetylated SUMO1 in complex with PML-SIM |
Heteromer P29590; | 98.67 | ||||
| Crystal structure of K39-acetylated SUMO1 in complex with phosphorylated PML-SIM |
Heteromer P29590; | 98.67 | ||||
| Ternary complex of SUMO1 with the SIM of PML and zinc |
Heteromer P29590; | 98.67 | 3×ZN; | |||
| Crystal structure of human Senp2 in complex with RanGAP1-SUMO-1 |
Heteromer P46060; Q9HC62; | 100 | ||||
| Non-covalent complex between human SUMO-1 and human Ubc9 |
Heteromer P63279; | 100 | ||||
| Crystal structure of DPP8 in complex with the EIL peptide (SLRFLFEGQRIADNH) |
Heteromer Q6V1X1; | 100 | 2×NA; | |||
| DPP8 - SLRFLYEG, space group 20 |
Heteromer Q6V1X1; | 87.5 | 2×FLC; 2×CA; 2×F15; | |||
| DPP8 - SLRFLYEG, space group 19 |
Heteromer Q6V1X1; | 87.5 | ||||
| STRUCTURE DETERMINATION OF THE SMALL UBIQUITIN-RELATED MODIFIER SUMO-1, NMR, 10 STRUCTURES | monomer | 100 | ||||
| Solution structure of human SUMO1 | monomer | 100 | ||||
| SOLUTION STRUCTURE OF LYS37 ACETYLATED HUMAN SUMO1 | monomer | 100 | ||||
| SOLUTION STRUCTURE OF LYS39 ACETYLATED HUMAN SUMO1 | monomer | 100 | ||||
| A conserved and buried edge-to-face aromatic interaction in SUMO is vital for the SUMO pathway | monomer | 98.97 | ||||
| Backbone fold of Human Small Ubiquitin like Modifier protein-1 (SUMO-1) based on Prot3D-NMR approac… | monomer | 100 | ||||
| Crystal structure of K39-acetylated SUMO1 in complex with phosphorylated DAXX | monomer | 98.73 | ||||
| Crystal Structure of SUMO1 in complex with phosphorylated Daxx | monomer | 98.73 | ||||
| Crystal Structure of SUMO1 in complex with Daxx | monomer | 98.72 | ||||
| Crystal structure of SUMO1 in complex with phosphorylated PIAS-SIM2 | monomer | 98.7 | ||||
| Crystal structure of K46-acetylated SUMO1 in complex with phosphorylated DAXX | monomer | 98.7 | ||||
| Crystal structure of K37-acetylated SUMO1 in complex with phosphorylated DAXX | monomer | 98.7 | ||||
| Crystal structure of SUMO1 in complex with PIAS-SIM2 | monomer | 98.68 | ||||
| Isoform-specific inhibition of SUMO-dependent protein-protein interactions | monomer | 100 | ||||
| Crystal structure of K37-acetylated SUMO1 in complex with PIAS-SIM2 | monomer | 98.65 | ||||
| Crystal structure of K37-acetylated SUMO1 in complex with phosphorylated PIAS-SIM2 | monomer | 98.63 | ||||
| Crystal structure of HERC2 ZZ domain in complex with SUMO1 tail | monomer | 100 | 2×ZN; 1×PEG; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2pe6.1.B | monomer | 0.78 | 100.00 | |||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 2iy1.1.B | monomer | 0.79 | 98.65 | |||